596 results on '"Lecour, Sandrine"'
Search Results
2. Heart rate – a novel target for treatment of peripartum cardiomyopathy?
3. Cardioprotection with Intralipid During Coronary Artery Bypass Grafting Surgery on Cardiopulmonary Bypass: A Randomized Clinical Trial
4. Effect of Remote Ischaemic Conditioning on the Inflammatory Cytokine Cascade of COVID-19 (RIC in COVID-19): a Randomized Controlled Trial
5. Interplay between the SAFE and the sphingolipid pathway for cardioprotection
6. Doxorubicin-induced cardiotoxicity and risk factors
7. RIC in COVID-19—a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19
8. Anthracycline-induced cardiotoxicity: targeting high-density lipoproteins to limit the damage?
9. People living with HIV display increased anti-apolipoprotein A1 auto-antibodies, inflammation, and kynurenine metabolites: a case–control study
10. Correction to: RIC in COVID-19—a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19
11. IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT) criteria: guidelines of the EU-CARDIOPROTECTION COST Action
12. Chronic and moderate consumption of reduced-alcohol wine confers cardiac benefits in a rat model of pulmonary arterial hypertension
13. The impact of sugar-sweetened beverage intake on rat cardiac function
14. Associations between high-density lipoprotein particle’s proteome, subfractions and autoantibodies against apolipoprotein A1 in HIV patients
15. Vasculature on the clock: Circadian rhythm and vascular dysfunction
16. Sphingosine-1-phosphate (S1P) activates STAT3 to protect against de novo acute heart failure (AHF)
17. Decreased Human Leukocyte Antigen DR on Circulating Monocytes Expression After Severe Pediatric Trauma: An Exploratory Report
18. Delivery Modes for Cardiac Stem Cell Therapy
19. Identification of potential biomarkers for predicting the early onset of diabetic cardiomyopathy in a mouse model
20. Animal models and animal-free innovations for cardiovascular research
21. Role of nuclear factor kappa-B in TNF-induced cytoprotection
22. Protection from Cardiovascular Disease Due to Increased High-Density Lipoprotein Cholesterol in African Black Populations : Myth or Reality?
23. Interaction of Cardiovascular Nonmodifiable Risk Factors, Comorbidities and Comedications With Ischemia/Reperfusion Injury and Cardioprotection by Pharmacological Treatments and Ischemic Conditioning
24. Doxorubicin-induced cardiotoxicity is associated with a change in high density lipoprotein subclasses in a mouse breast cancer model
25. Effect of Remote Ischaemic Conditioning on the Inflammatory Cytokine Cascade of COVID-19 (RIC in COVID-19): a Randomized Controlled Trial
26. The potential benefit of rooibos (Aspalathus linearis) in pulmonary arterial hypertension: A short review
27. Redox Regulatory Changes of Circadian Rhythm by the Environmental Risk Factors Traffic Noise and Air Pollution
28. Extracellular vesicles in diagnostics and therapy of the ischaemic heart: Position Paper from the Working Group on Cellular Biology of the Heart of the European Society of Cardiology
29. Remote ischaemic conditioning: in search of a suitable match
30. The 10th Biennial Hatter Cardiovascular Institute workshop: cellular protection—evaluating new directions in the setting of myocardial infarction, ischaemic stroke, and cardio-oncology
31. Exercise intervention alters HDL subclass distribution and function in obese women
32. The SAFE pathway for cardioprotection: is this a promising target?
33. Finding the culprit for the failure of the immune clock as time goes by
34. The Role of Immune and Inflammatory Cytokines in Ischemic Preconditioning of the Heart — Identification of Novel Cardiac Cell Survival Signaling Programs
35. Identification and role of inflammatory oxygen free radicals in cardiac ischemia and reperfusion injury
36. A comprehensive review: the evolution of animal models in pulmonary hypertension research; are we there yet?
37. Animal models and animal-free innovations for cardiovascular research: current status and routes to be explored. Consensus document of the ESC working group on myocardial function and the ESC Working Group on Cellular Biology of the Heart
38. Animal models and animal-free innovations for cardiovascular research: current status and routes to be explored. Consensus document of the ESC working group on myocardial function and the ESC Working Group on Cellular Biology of the Heart.
39. Animal models and animal-free innovations for cardiovascular research: current status and routes to be explored. Consensus document of the ESC working group on myocardial function and the ESC Working Group on Cellular Biology of the Heart
40. Redox Regulatory Changes of Circadian Rhythm by the Environmental Risk Factors Traffic Noise and Air Pollution
41. Animal models and animal-free innovations for cardiovascular research: current status and routes to be explored. Consensus document of the ESC Working Group on Myocardial Function and the ESC Working Group on Cellular Biology of the Heart
42. Circadian rhythms in ischaemic heart disease: key aspects for preclinical and translational research: position paper of the ESC working group on cellular biology of the heart
43. Melatonin as a cardioprotective therapy following ST-segment elevation myocardial infarction: is it really promising? Reply
44. Epigenomic and transcriptomic approaches in the post-genomic era: path to novel targets for diagnosis and therapy of the ischaemic heart? Position Paper of the European Society of Cardiology Working Group on Cellular Biology of the Heart
45. Novel targets and future strategies for acute cardioprotection: Position Paper of the European Society of Cardiology Working Group on Cellular Biology of the Heart
46. Novel putative pharmacological therapies to protect the right ventricle in pulmonary hypertension: a review of current literature
47. Position Paper of the European Society of Cardiology Working Group Cellular Biology of the Heart: cell-based therapies for myocardial repair and regeneration in ischemic heart disease and heart failure
48. Role of toll-like receptor 4 in melatonin-induced cardioprotection
49. Delivery Modes for Cardiac Stem Cell Therapy
50. Ischaemic conditioning and targeting reperfusion injury: a 30 year voyage of discovery
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.